IMARC Group, one of the world’s leading research and
advisory firms, finds that the total number of diabetes patients in India grew
at CAGR of nearly 3% during 2004 - 2012. Estimates from their latest report
entitled “Indian Diabetes Market Report: Epidemiology, Patients, Prevalence,
Oral Anti-diabetics, Insulin and Diagnostics”, suggests that the total number
of diabetes patients in India is expected to reach 107 million by 2032.
Findings from the report suggest that a major driver
of the diabetes epidemic in India is the increasing levels of obesity. The
Indian population that had faced under nutrition for a long time is now exposed
to high fat diets and sedentary lifestyles. As a result of increasing
disposable incomes and flourishing fast food chains, there were around 157
million overweight and 24 million obese people living in India in 2010. The
report expects these levels to increase significantly by 2015.
Apart from the increasing obesity levels, the report
also found that Indians are genetically more vulnerable to diabetes compared to
other population groups. According to an analyst at IMARC Group “As a result of
a higher percentage of body fat to muscle, Indians are more vulnerable to
type-2 diabetes compared to other population groups. This fat increases the
sugar levels as it gets deposited around the abdomen and interferes with
insulin. As a result, Indians get diabetes at a much younger age compared to
other population groups”.
IMARC’s new report “Indian Diabetes Market Report:
Epidemiology, Patients, Prevalence, Oral Anti-diabetics, Insulin and
Diagnostics” provides an analytical and statistical insight into the Indian
diabetes market. The report provides both current and future trends in the
prevalence, demographical breakup, diagnosis and treatment of diabetes in
India. The report has segmented the Indian diabetes market into three segments
- Oral Anti-diabetics, Insulin and Diabetes Diagnostics. For each of the
aforementioned categories, the report provides historical and future market
sales, performance of key classes and the performance of top players.
The research study serves as an exceptional tool to
understand the epidemiology, market trends, therapeutic structure, competitive
structure and the outlook of the Indian diabetes market. This report can serve
as an excellent guide for investors, researchers, consultants, marketing
strategists and all those who are planning to foray into the Indian diabetes
market in some form or the other.
